Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q2 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $500 thousand.

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.